Matches in Wikidata for { <http://www.wikidata.org/entity/Q66033559> ?p ?o ?g. }
Showing items 1 to 31 of
31
with 100 items per page.
- Q66033559 description "clinical trial" @default.
- Q66033559 description "ensayu clínicu" @default.
- Q66033559 description "klinisch onderzoek" @default.
- Q66033559 description "клінічне випробування" @default.
- Q66033559 name "Efficacy and Safety of a Long Acting Anti-Psychotic Versus Placebo in Patients With Schizophrenia" @default.
- Q66033559 name "Efficacy and Safety of a Long Acting Anti-Psychotic Versus Placebo in Patients With Schizophrenia" @default.
- Q66033559 type Item @default.
- Q66033559 label "Efficacy and Safety of a Long Acting Anti-Psychotic Versus Placebo in Patients With Schizophrenia" @default.
- Q66033559 label "Efficacy and Safety of a Long Acting Anti-Psychotic Versus Placebo in Patients With Schizophrenia" @default.
- Q66033559 prefLabel "Efficacy and Safety of a Long Acting Anti-Psychotic Versus Placebo in Patients With Schizophrenia" @default.
- Q66033559 prefLabel "Efficacy and Safety of a Long Acting Anti-Psychotic Versus Placebo in Patients With Schizophrenia" @default.
- Q66033559 P1050 Q66033559-521FC044-A7A8-4970-B889-31E45169F8D7 @default.
- Q66033559 P1132 Q66033559-9CEE149D-D5B6-4FF4-8D00-19BDA32F01CD @default.
- Q66033559 P1476 Q66033559-E1CE9492-8D08-434C-8D11-AB69E49AEA79 @default.
- Q66033559 P2899 Q66033559-5B83CB22-8A05-4985-B41F-DFCCA0B0B768 @default.
- Q66033559 P3098 Q66033559-A66A099E-CA51-41C7-9CC4-3A72FB6E9514 @default.
- Q66033559 P31 Q66033559-3EE0D4AA-7381-4031-ADFB-49A95BF805A6 @default.
- Q66033559 P4844 Q66033559-7E142F90-7996-40DC-AE97-1C8A33F1529D @default.
- Q66033559 P580 Q66033559-A0F8204E-956B-4A5A-BF7B-B3785F59D1F6 @default.
- Q66033559 P6099 Q66033559-F7B3B5FE-C303-40C0-93CC-8D4E7CD0DC53 @default.
- Q66033559 P8363 Q66033559-6C2983EB-D6A4-4C63-8A66-0E267F395CE4 @default.
- Q66033559 P1050 Q41112 @default.
- Q66033559 P1132 "+518" @default.
- Q66033559 P1476 "A Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-response Study to Evaluate the Efficacy and Safety of 3 Fixed Doses (25 mg eq, 50 mg eq, and 100 mg eq) of Paliperidone Palmitate in Patients With Schizophrenia" @default.
- Q66033559 P2899 "+18" @default.
- Q66033559 P3098 "NCT00101634" @default.
- Q66033559 P31 Q30612 @default.
- Q66033559 P4844 Q27157250 @default.
- Q66033559 P580 "2004-12-01T00:00:00Z" @default.
- Q66033559 P6099 Q42824827 @default.
- Q66033559 P8363 Q78089383 @default.